McKechnie Duncan

Track

Insider profile

McKechnie Duncan's trades of Vertex Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
486.38
Quantity 5,847
Value US$1,847,238
Transaction date
Proposed sale
Price
498.42
Quantity 2,633
Value US$1,312,340
Transaction date
Proposed sale
Price
475.30
Quantity 2,437
Value US$1,158,306
Transaction date
Proposed sale
Price
487.65
Quantity 4,910
Value US$2,394,365
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-02
PlS Planned sale
51,512 -33.2%
47.60
US$3,466,787 		51,512 -33.2% 47.60 US$3,466,787
2026-07-02 2026-07-02
PrS Proposed sale
5,847
486.38
US$1,847,238 		5,847 486.38 US$1,847,238
2026-03-13 2026-03-11
PlS Planned sale
66,076 -21.7%
323.15
US$2,342,144 		66,076 -21.7% 323.15 US$2,342,144
2026-03-11 2026-03-11
PrS Proposed sale
2,633
498.42
US$1,312,340 		2,633 498.42 US$1,312,340
2026-03-06 2026-03-04
PlS Planned sale
2,437 -13.9%
475.30
US$1,158,306 		2,437 -13.9% 475.30 US$1,158,306
2026-03-04 2026-03-04
PrS Proposed sale
2,437
475.30
US$1,158,306 		2,437 475.30 US$1,158,306
2026-02-26 2026-02-25
PlS Planned sale
2,410 -12.1%
489.00
US$1,178,490 		2,410 -12.1% 489.00 US$1,178,490
2026-02-26 2026-02-25
PlS Planned sale
2,500 -11.1%
486.35
US$1,215,875 		2,500 -11.1% 486.35 US$1,215,875
2026-02-25 2026-02-25
PrS Proposed sale
4,910
487.65
US$2,394,365 		4,910 487.65 US$2,394,365